111 related articles for article (PubMed ID: 21467651)
1. Characterization of transcutaneous protein delivery by a hydrogel patch in animal, human, and tissue-engineered skin models.
Matsuo K; Ishii Y; Quan YS; Kamiyama F; Mukai Y; Okada N; Nakagawa S
Biol Pharm Bull; 2011; 34(4):586-9. PubMed ID: 21467651
[TBL] [Abstract][Full Text] [Related]
2. Compositional optimization and safety assessment of a hydrogel patch as a transcutaneous immunization device.
Matsuo K; Ishii Y; Quan YS; Kamiyama F; Asada H; Mukai Y; Okada N; Nakagawa S
Biol Pharm Bull; 2011; 34(12):1835-40. PubMed ID: 22130239
[TBL] [Abstract][Full Text] [Related]
3. Analysis of transcutaneous antigenic protein delivery by a hydrogel patch formulation.
Matsuo K; Ishii Y; Kawai Y; Saiba Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
J Pharm Sci; 2013 Jun; 102(6):1936-1947. PubMed ID: 23585300
[TBL] [Abstract][Full Text] [Related]
4. Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria.
Hirobe S; Matsuo K; Quan YS; Kamiyama F; Morito H; Asada H; Takaya Y; Mukai Y; Okada N; Nakagawa S
Vaccine; 2012 Feb; 30(10):1847-54. PubMed ID: 22230592
[TBL] [Abstract][Full Text] [Related]
5. Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat.
Matsuo K; Ishii Y; Quan YS; Kamiyama F; Mukai Y; Yoshioka Y; Okada N; Nakagawa S
J Control Release; 2011 Jan; 149(1):15-20. PubMed ID: 20493218
[TBL] [Abstract][Full Text] [Related]
6. A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection.
Ishii Y; Nakae T; Sakamoto F; Matsuo K; Matsuo K; Quan YS; Kamiyama F; Fujita T; Yamamoto A; Nakagawa S; Okada N
J Control Release; 2008 Oct; 131(2):113-20. PubMed ID: 18700159
[TBL] [Abstract][Full Text] [Related]
7. Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device.
Hirobe S; Azukizawa H; Matsuo K; Zhai Y; Quan YS; Kamiyama F; Suzuki H; Katayama I; Okada N; Nakagawa S
Pharm Res; 2013 Oct; 30(10):2664-74. PubMed ID: 23775442
[TBL] [Abstract][Full Text] [Related]
8. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.
Matsuo K; Yokota Y; Zhai Y; Quan YS; Kamiyama F; Mukai Y; Okada N; Nakagawa S
J Control Release; 2012 Jul; 161(1):10-7. PubMed ID: 22306332
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of transdermal protein delivery by photothermal effect of gold nanorods coated on polysaccharide-based hydrogel.
Haine AT; Koga Y; Hashimoto Y; Higashi T; Motoyama K; Arima H; Niidome T
Eur J Pharm Biopharm; 2017 Oct; 119():91-95. PubMed ID: 28600224
[TBL] [Abstract][Full Text] [Related]
10. Transcutaneous immunization with Intercell's vaccine delivery system.
Seid RC; Look JL; Ruiz C; Frolov V; Flyer D; Schafer J; Ellingsworth L
Vaccine; 2012 Jun; 30(29):4349-54. PubMed ID: 22682290
[TBL] [Abstract][Full Text] [Related]
11. [Development of transcutaneous vaccination system for infectious disease countermeasure].
Matsuo K
Yakugaku Zasshi; 2012; 132(12):1443-50. PubMed ID: 23208052
[TBL] [Abstract][Full Text] [Related]
12. Transcutaneous vaccines--current and emerging strategies.
Hirobe S; Okada N; Nakagawa S
Expert Opin Drug Deliv; 2013 Apr; 10(4):485-98. PubMed ID: 23316778
[TBL] [Abstract][Full Text] [Related]
13. Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays.
Guo L; Qiu Y; Chen J; Zhang S; Xu B; Gao Y
Biomed Microdevices; 2013 Dec; 15(6):1077-85. PubMed ID: 23893014
[TBL] [Abstract][Full Text] [Related]
14. Transcutaneous immunization by lipoplex-patch based DNA vaccines is effective vaccination against Japanese encephalitis virus infection.
Cheng JY; Huang HN; Tseng WC; Li TL; Chan YL; Cheng KC; Wu CJ
J Control Release; 2009 May; 135(3):242-9. PubMed ID: 19331858
[TBL] [Abstract][Full Text] [Related]
15. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.
Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL
Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818
[TBL] [Abstract][Full Text] [Related]
16. Development and in vitro evaluation of a transdermal hydrogel patch for ferulic acid.
Bai J; Lu Y; Li PY; Liu CM; Wu HC; Wen R; Du SY
Pak J Pharm Sci; 2014 Mar; 27(2):369-75. PubMed ID: 24577928
[TBL] [Abstract][Full Text] [Related]
17. [Development of a transcutaneous vaccination system using a hydrogel patch].
Ishii Y; Okada N; Nakagawa S
Nihon Rinsho; 2008 Oct; 66(10):1848-50. PubMed ID: 18939480
[No Abstract] [Full Text] [Related]
18. In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride.
Nair AB; Vaka SR; Gupta S; Repka MA; Murthy SN
Pharm Dev Technol; 2012; 17(2):158-63. PubMed ID: 20958130
[TBL] [Abstract][Full Text] [Related]
19. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
[TBL] [Abstract][Full Text] [Related]
20. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
